Trusted News Discovery Since 2008
{{/content}}
Coronavirus Vaccine From China Is Safe In Early Trial
Video Credit: Wochit
Published on May 22, 2020 - Duration: 00:40s
Coronavirus Vaccine From China Is Safe In Early Trial
A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe.
It induced a rapid immune response in its first human trial, Reuters reports.
This vaccine did not cause any serious adverse effects, though side effects such as fever were noted.
Blood samples from the 108 vaccinated adults showed "neutralizing antibodies" and T-cell responses.
However, the ability to trigger these immune responses does not necessarily indicate that the vaccine works.
Scientists are still a long way from this vaccine being available to people around the world.
The first such trial to confirm whether the vaccine protects against infection is underway in Wuhan.
You are here
Related news from verified sources
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the...
on May 22, 2020 • Reuters India
A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on...
on May 22, 2020 • Reuters India
Related videos from verified sources
Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine 00:32
Video credit: Wochit - Published on May 22, 2020
AstraZeneca to make billion COVID vaccine doses if tests succeed 01:20
Video credit: Reuters Studio - Published on May 21, 2020
Wall Street drops as investors lose confidence 02:08
Video credit: Reuters Studio - Published on May 19, 2020